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Brown adipocytes differentiated in primary cell culture were found to contain a type II iodothyronine 5'-deiodinase (5'D). Incubation of confluent 
cells with norepinephrine ordibutyryl-cAMP caused up to 17-fold increase in 5'D activity with a maximum after 8 h. Activation of 5'D required 
mRNA and protein synthesis and was accompanied by parallel, up to 5.8-fold increase in the amount of mitochondrial uncoupling protein with 
a maximum after 24 h. Analysis of adrenergic stimulation of 5'D suggested predominant i volvement of the fl-receptors and increased intracellular 
cAMP levels, while the contribution of~-receptors was small. 
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1. INTRODUCTION 
Brown adipose tissue (BAT),  the major  site of  non- 
shivering thermogenesis in newborn and cold- 
accl imated animals (for review see [1]) contains, 
s imi lar ly to the brain,  p i tu i tary and pineal gland, type II 
iodothyron ine 5 ' -de iod inase  (5 'D)  [2]. In contrast  to 
type I enzyme present in liver and kidney, type II 5 'D  
is insensitive to propylth iouraci l ,  exhibits dif ferent 
kinetics and has low gm values for T4 and reverse T3 in 
the nanomolar  ange [3,4]. 
Act iv i ty of  5 'D  in BAT is largely st imulated uring 
per inatal  recruitment o f  thermogenic funct ion [5-7], in 
hypothyro id  and cold-exposed animals [8-11] and by 
sympathet ic  st imulat ion [12]. The local product ion of  
T3 by 5 'D  in BAT in concurrence with norepinephr ine 
[13,14] is essential for the synthesis of  mitochondr ia l  
uncoupl ing protein (UCP),  the key and rate- l imit ing 
component  of  BAT thermogenesis [1,15]. When fully 
act ivated, 5 'D  of  BAT represents a substantial  source 
of  systemic T3, in hypothyro id  animals in part icular 
[9-11]. 
Hormona l  regulat ion of  5 'D  in BAT is still not very 
clear. Involvement of  oq-adrenergic receptors in activa- 
t ion of  5 'D  by norepinephr ine was demonstrated in 
vivo [12] but a large increase in 5'  D activity was also in- 
duced by isoproterenol ,  insulin and glucagon [16]. Ac- 
t ivat ion by insulin and Odl- but not/3-adrenergic agonists 
was further observed in some experiments with isolated 
adipocytes from rat BAT [17,18], while in others [19], 
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a pronounced effect of/3- and synergistic inf luence of  
a l -adrenerg ic  agents was found. 
Exper iments are reported here that were carr ied out 
to examine 5 'D  in brown adipocytes which dif feren- 
t iated in pr imary culture f rom precursor cells to a state 
al lowing full expression of  the UCP gene [20]. 
2. MATERIALS  AND METHODS 
The stromal-vascular cells from BAT of 3-4-week-old mice 
(Balb/c, outbred strain) were isolated and cultivated as previously 
described [20] at a standard inoculation of 2 x 104 cells/cm z in 35-mm 
Petri dishes using modified [20,21] Eagle's minimal essential medium 
containing 10°70 fetal calf serum. Experiments were performed with 
cells cultured for 7 days. Incubation of cells with the agents indicated 
was terminated by two brief washes with PBS and cells were harvested 
by scraping into 150 #1 PBS. They were homogenized (10 s sonication) 
and frozen in liquid nitrogen for later analysis. 
5'D activity was assayed according to [3] with the following 
modifications: the incubation mixture (200 tzl) contained 100 mM 
sodium phosphate (pH 7.0), i mM EDTA, 10 mM DTT, 0.15 nM 
[t231]T4 ( -  50000 cpm of L-[3',5'-I25I]T4, > 44TBq/g; from IZIN- 
TA, Hungary), 2.25 nM unlabeled "1"4 and 1 mM 6-n- 
propyl-2-thiouracil. After 1 h at 37°C, 50 #1 of 2°70 BSA was added 
followed by 350 #1 of ice-cold 10070 TCA. Released 123I- was 
separated from iodothyronines on Dowex 50W-X2 columns and 
counted as previously described [3]. The tracer was purified by paper 
electrophoresis before ach assay and blank values (no protein) were 
less than 1 °70 of the radioactivity added. The results are expressed as 
fmol T3 produced per h per mg protein. 
The content of mitochondrial UCP was measured by immunoblot- 
ting as before [6,20]. The protein content was determined as described 
[22] using BSA as standard. 
Norepinephrine, isoprenaline, phenylephrine, propranolol, for- 
skolin, dibutyryl-cAMP and cycloheximide were from Sigma, 
prazosin from Pfizer and actinomycin D from Merck. 
3. RESULTS AND DISCUSSION 
Abbreviations: BAT, brown adipose tissue; dbcAMP, dibutyryl- 
cAMP; 5' D, iodothyronine 5 '-deiodinase; UCP, uncoupling protein 
Cultured BAT cells produced around conf luence (6-7 
days after inoculat ion) a measurable 5 'D  activity as 
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Fig. 1. Time course (A) and concentration dependence (B) of the in- 
crease in 5' D activity induced by 10 tiM norepinephrine (o) and 1 mM 
dibutyryl-cAMP (o). In B, cultured cells were exposed for 24 h to.the 
indicated concentration f norepinephrine. Values are the means of 
two independent experiments performed in duplicate. 
well as a detectable amount  of  spontaneously s nthesiz- 
ed UCP.  When the 7-day cells were supplemented with 
10 #M norepinephr ine or 1 mM d ibutyry l -cAMP 
(dbcAMP) ,  5 'D  became largely st imulated resulting in 
a maximal ly  7- fo ld  and 17-fold increase in 5 'D  activi- 
ty, respectively (Fig. 1A). The t ime course of  both the 
norepinephr ine and dbcAMP effect on 5' D is seen to be 
similar. Whi le the enzyme activity quickly increased 
during the first 8-12 h there was no measurable increase 
in the 5 'D  activity in control  cells for 24 h. The 
dose-response curve for norepinephr ine st imulat ion of  
5 'D  was s igmoid with a max imum at 10 #M 
norepinephr ine (Fig. 1B). When exposed to 
norepinephr ine or dbcAMP for more than 24 h cells 
started to detach f rom the dishes. 
The Km for T4 of  the 5 'D  induced in cultured adi- 
pocytes by norepinephr ine and dbcAMP was around 
10-  9 M, similar to microsomes of  cerebral  cortex [3] or 
in f ranatants  of  BAT [3] f rom hypothyro id  adult  rats. 
The 5 'D  of  cultured cells was also insensitive to 1 mM 
propyl th iourac i l  ( ower than 10°70 inhibit ion at 0.2 nM 
and 2 nM T4 as substrate).  Therefore,  the 5' D induced 
in brown adipocytes di f ferent iated in cell culture cor- 
responds to the type II enzyme present in BAT of  dif- 
ferent rodent species [2,10] and not to the type I enzyme 
of  ovine and bovine BAT [23,24]. 
Incubat ion of  cultured adipocytes with dbcAMP (1 
mM) together with cycloheximide (10 #g/ml)  or ac- 
t inomycin D (60 ng/ml)  which were added 10 min 
before addit ion of  dbcAMP completely prevented the 
st imulatory effect of  dbcAMP (Table I). This suggests 
that act ivat ion of  5'  D in cultured cells is fully based on 
de novo protein synthesis which requires active mRNA 
synthesis and is not due to increased translat ion of  pre- 
existing mRNA,  similarly as in the case of  norepine- 
Table 1 
Effect of cycloheximide and actinomycin D on dibutyryl-cAMP- 
stimulated 5'D activity in cultured BAT cells 
Cell treatment 5' D activity 
(fmol T3/h/mg protein) 
(A) 
dbcAMP (l mM) 109.2 
dbcAMP + cycloheximide (10 #g/ml) 0 
dbcAMP + actinomycin D (60 ng/ml) 2.6 
(B) 
dbcAMP (1 mM) 90.1 
dbcAMP + cycloheximide (10 #g/ml) 20.5 
dbcAMP + actinomycin D (60 ng/ml) 22.7 
In (A), cells were exposed for 8 h to dbcAMP and inhibitors were add- 
ed 10 min before dbcAMP. In (B), cells were exposed to dbcAMP for 
24 h and inhibitors were present for the last 16 h (added 8 h after 
dbcAMP). The values are the means of 2 experiments performed in 
duplicate. 
phrine- and cold-act ivated BAT 5 'D  in vivo [16,25]. 
Both inhibitors also induced large and rather fast 
decrease of  5 'D  when added 8 h after dbcAMP (Table 
I). This implies fast turnover of  both the 5 'D  protein 
and its mRNA,  in agreement with their short half- l ives 
observed in vivo (to.s of  protein 0.4-0.7 h, to.s of  mRNA 
below 2 h [16,25]). 
Add i t ion  of  norepinephr ine and dbcAMP to cultured 
adipocytes markedly  elevated also the specific content 
of  UCP (Fig. 2). In contrast  to changes in 5 'D ,  the 
UCP content cont inuously increased with time until the 
max imum was obtained after 24 h (4.9-fold and 
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Fig. 2. Specific ontent of mitochondrial uncoupling protein (UCP) in 
cells exposed to norepinephrine and dibutyryl-cAMP. Cultured BAT 
cells were incubated for the indicated times with 10 #M ( [] ) or 0.1 #M 
norepinephrine ( • ) or 1 mM dbcAMP (e). Untreated cells (o) served 
as controls. 10/zg protein aliquots of ceils harvested by scraping were 
analysed by immunoblotting for UCP content. Data are the means of 
two experiments performed in duplicate. 
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Table II 
Effects of adrenergic and cAMP-concentration-modulating agents on 
5'D activity in cultured BAT cells 
Agent 5' D activity 
(fmol T3/h/mg protein) (n) 
Control 6.0 + 3.7 23 
Norepinephrine (10/~M) 42.4 + 12.1 12 
Isoprenaline (10 t~M) 37.2 _+ 9.5 7 
Phenylephrine (10 #M) 8.8 _+ 8.4 5 
Forskolin (1 /~M) 98.2 _+ 38.3 5 
dbcAMP (1 #M) 101.1 + 36.7 7 
Norepinephrine (1#M) 27.1 + 5.1 6 
+ propranolol (10 #M) 9.8 _+ 3.7 4 
+ prazosin (10 #M) 21.3 _+ 5.7 4 
Cultured BAT cells were exposed for 8 h to the agents indicated. 
Values are the means + SD from n experiments performed in 
duplicate. 
5.8-fold,  respectively) and the optimal concentration of  
norepinephrine was 0.1 #M. The lower induction of  
UCP  at 10 #M norepinephrine is in accordance with 
previous data on synthesis of  UCP  and its mRNA in 
postconfluent cells [7,20,26]. The data indicate that the 
same adrenergic and cAMP-mediated stimulation ac- 
tivates the synthesis of  both 5' D and UCP but the con- 
trol o f  expression of  the two genes appears to be dif- 
ferent. This is not surprising in the light of  evidence that 
active 5 'D  and binding of  locally produced T3 to 
nuclear receptors [27] is required for induction of  UCP  
synthesis. Interestingly, the perinatal development of  
BAT in several species shows coincidental, but not ex- 
actly parallel changes in 5' D activity and UCP content 
[5,7,24,28]. 
The extent of  stimulation of  5' D activity in cultured 
BAT cells exposed for 8 h to different adrenergic and 
cAMP modulating agents is shown in Table II. 
Isoproterenol (10 #M), the ~-selective agonist, was 
found to be similarly effective as o~t,/3-agonist, 10/~M 
norepinephrine (6.2-7-fold increase, respectively) while 
the effect of  the al-agonist phenylephrine (10 #M) was 
negligible. An even more pronounced, 16-fold increase 
in 5 'D  activity was induced by 1 #M forskolin, an ac- 
tivator of  adenylate cyclase, in agreement with activa- 
tion o f  5 'D  caused by membrane-permeant dbcAMP (1 
mM). The effect of  the subtype-selective adrenergic an- 
tagonists was tested by using propranolol  and prazosin 
in a 10-fold excess over norepinephrine (Table II). The 
induction of  5' D activity in cultured brown adipocytes 
by 1/~M norepinephrine was almost completely abolish- 
ed (82%) by 10 #M propranolol ,  the /3-selective an- 
tagonist. The a~-selective antagonist prazosin (10/~M) 
was significantly less inhibitory and prevented only 
27% of  norepinephrine-induced 5 'D  activity. 
The results obtained with cultured BAT cells thus 
convincingly demonstrate that adrenergic stimulation 
of  5 'D  synthesis involves predominantly/3-adrenergic 
receptors and changes in cellular cAMP,  similarly as 
found in cultured astroglial cells [29], or pineal glands 
[30]. The large extent of  5 'D  stimulation and in vitro 
conditions rule out the possibility of  an indirect effect 
of  13-agonist [16]. At variance with in vivo experiments 
[12,16], and experiments with cells isolated from BAT 
of  euthyroid and hypothyroid rats [19], little stimula- 
tion of  5' D by phenylephrine and low inhibitory effect 
o f  prazosin as well as significantly higher activation of  
5' D by dbcAMP and forskolin than by norepinephrine 
suggest hat o~l-receptors are only weakly involved in 
adrenergic stimulation of  5 'D  in cultured BAT cells. 
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